Healthcare -
Biotechnology - NASDAQ - US
$ 1.05
2.94 %
$ 57.8 M
Market Cap
-0.59
P/E
PRLD - NET CHANGE IN CASH
Net Change in Cash PRLD - Prelude Therapeutics Incorporated
-5.31 M
LAST VALUE
82.93%
2 YEAR CAGR
-17.01%
5 YEAR CAGR
0.00%
10 YEAR CAGR